Article Figures & Data
Figures
- Figure 1.
GIST Survival: Imatinib Versus Doxorubicin.
GIST=gastrointestinal stromal tumor.
Reprinted from Verweij J et al. Progression-free Survival in Gastrointestinal Stromal Tumours with High-Dose Imatinib: Randomised Trial. The Lancet;364(9440):1127–34. Copyright 2004, with permission from Elsevier.
Tools
A Paradigm Shift in Early Drug Development: Individualizing to More Patient Benefit
Permalink:
Table of contents
Cited By...
- No citing articles found.